Casein Hydrolysate Alleviates Adipose Chronic Inflammation in High Fat-Diet Induced Obese C57BL/6J Mice through MAPK Pathway.
Casein Hydrolysate Alleviates Adipose Chronic Inflammation in High Fat-Diet Induced Obese C57BL/6J Mice through MAPK Pathway.
复制标题
酪蛋白水解物通过MAPK途径减轻高脂饮食诱导的肥胖C57 BL/6 J小鼠脂肪慢性炎症
作者:
Liu L;Yu S;Bu T;He G;Li S;Wu J
Obesity-induced adipose chronic inflammation is closely related to the development of insulin resistance and T2DM. Tripeptides l-valyl-l-prolyl-l-proline (VPP) and l-isoleucyl-l-prolyl-L-proline (IPP) derived from bovine casein have been reported to prevent inflammatory changes and mitigate insulin resistance in adipocytes. In this study, we aimed to investigate the influence of casein hydrolysates (CH) containing VPP and IPP on a high fat diet (HFD)-induced obese mice and cytokine TNF-α-induced adipocytes. Our data showed that CH alleviated chronic inflammation both in vivo and in vitro. 4% CH suppressed HFD-induced systemic inflammatory factors, hypertrophic white adipocytes, and macrophage infiltration. More importantly, CH was able to improve adipocyte dysfunction induced by TNF-α by increasing the expression of CCAAT/enhancer binding protein α (C/EBP-α) rather than peroxisome proliferator-activated receptor γ (PPAR-γ). Furthermore, CH also dose-dependently suppressed mitogen-activated protein kinase (MAPK)-c-Jun N-terminal kinase (JNK) phosphorylation and enhanced the phosphorylation of Erk 1/2, but not nuclear factor-kappa B (NF-κB) p65 phosphorylation, in TNF-α-induced 3T3-L1 cells. These results indicated that CH could ameliorate adipose chronic inflammation through the MAPK pathway. Altogether, our findings suggested that 4% CH supplementation for 6 weeks exerted a protective role in preventing obesity-related inflammation and adipose dysfunction.
登录
查看更多内容
影响因子:
3.6
作者:
Aihara, Kotaro;Osaka, Mizuko;Yoshida, Masayuki
通讯作者:
Yoshida, Masayuki
影响因子:
7
作者:
Coppack, SW
通讯作者:
Coppack, SW
影响因子:
6.1
作者:
Chakrabarti, Subhadeep;Jahandideh, Forough;Wu, Jianping
通讯作者:
Wu, Jianping
影响因子:
3.7
作者:
Hagita S;Osaka M;Shimokado K;Yoshida M
通讯作者:
Yoshida M
DOI:
10.1016/s0140-6736(16)30054-x
发表时间:
2016-04-02
期刊:
Lancet (London, England)
影响因子:
--
作者:
NCD Risk Factor Collaboration (NCD-RisC)
通讯作者:
NCD Risk Factor Collaboration (NCD-RisC)